Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 3, Issue 2, pp. 116-124
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 26, 2014
- Revision received November 7, 2014
- Accepted December 8, 2014
- Published first December 16, 2014.
Article Versions
- Previous version (December 16, 2014 - 05:54).
- Previous version (January 22, 2015 - 07:57).
- You are viewing the most recent version of this article.
Copyright & Usage
©2014 American Association for Cancer Research.
Author Information
- Melissa M. Berrien-Elliott1,
- Jinyun Yuan1,
- Lauryn E. Swier1,
- Stephanie R. Jackson1,
- Collin L. Chen1,
- Maureen J. Donlin1,2, and
- Ryan M. Teague1,3,*
- 1Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri.
- 2Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri.
- 3Saint Louis University Cancer Center, St. Louis, Missouri.
- ↵*Corresponding Author:
Ryan M. Teague, Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 South Grand Boulevard, Doisy Research Center Room 705, St. Louis, MO 63104. Phone: 314-977-8871; Fax: 314-977-8717; E-mail: rteague{at}slu.edu
February 2015
Volume 3, Issue 2
Volume 3, Issue 2
Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells
Jump to section
Advertisement